Should you test or treat partners of patients with gonorrhea, chlamydia, or trichomoniasis?
Metadata[+] Show full item record
Empiric treatment of partners of female or heterosexual male patients diagnosed with gonorrhea or chlamydia using expedited partner therapy (having the index patient deliver therapy to the partner) decreases the risk of persistent or recurrent infection in the index patient (strength of recommendation [SOR]: A, metaanalysis). The effect is greater for gonorrhea than chlamydia. By contrast, expedited partner therapy for trichomoniasis appears equivalent to a test-first approach (SOR: B, single randomized controlled trial [RCT]).
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.